US Patent Issued to GigaGen on Sept. 23 for "Anti-CTLA-4 binding proteins and methods of use thereof" (California Inventors)

ALEXANDRIA, Va., Sept. 23 -- United States Patent no. 12,421,311, issued on Sept. 23, was assigned to GigaGen Inc. (San Carlos, Calif.).

"Anti-CTLA-4 binding proteins and methods of use thereof" was invented by David Scott Johnson (San Francisco), Adam Shultz Adler (Belmont, Calif.), Rena Aviva Mizrahi (Pacifica, Calif.), Yoong Wearn Lim (Pacifica, Calif.), Michael Asensio (Mountain View, Calif.) and Erica Lyn Stone (San Bruno, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are antigen-binding proteins (ABPs) that selectively bind to CTLA-4 and its isoforms and homologs, and compositions comprising the ABPs. Also provided are methods of using the ABPs, such as therapeutic and diagnosti...